SGLT2 inhibition: A possible mode-of-action for inflammatory skin diseases? Presented ByAllison Holt, UMass Chan Medical School, USA ConferenceAAD 2024 22 April, 2024 15:06
Roflumilast foam led to high response rates in seborrheic dermatitis Presented ByProf. Andrew Blauvelt, Oregon Medical Research Center, OR, USA TrialPhase 3, STRATUM ConferenceEADV 2022 5 November, 2022 09:00